It was ABBA that most memorably lamented “breaking up is never easy, I know”, but it’s clearly a sentiment with which EverBlu Capital chairman Adam Blumenthal could agree.

Blumenthal resigned his secondary role as chairman of ASX-listed pot stock Creso Pharma on November 25, three days after the Australian Securities and Investments Commission enacted a Section 33 notice on EverBlu (aided by Federal Police raids at the stockbroker’s Aurora Place office and Blumenthal’s home).